Background Microplastics (MPs) have been identified in different types of tissue, including lung, bowel, placenta and as well in human whole blood [1]. During analysis of synovial fluid samples with ...
2 Azienda Zero, Veneto Region, Clinical governance Unit, Padua, Italy 3 Azienda Zero, Veneto Region, Epidemiological Department, Padua, Italy 4 Azienda Zero, Veneto Region, Clinical governance Unit, ...
Background The trend of, and the impact of major organ damage on the short- and longer-term survival of patients with systemic lupus erythematosus (SLE) globally over the past 60 years have not been ...
2 Kyverna Therapeutics, Technical Operations, Emeryville, United States of America 3 Friedrich Alexander University Erlangen, University Hospital Erlangen, Internal Medicine 5 – Hematology/Oncology, ...
Correspondence to Eloisa Bonfa, Rheumatology Division, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo 04746-070, Brazil; eloisa.bonfa{at}hc.fm.usp.br Objective To evaluate the effect on ...
Background Despite treatment according to the current management recommendations, a significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These patients can be ...
Correspondence to Dr G Caleb Alexander, Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA; galexan9{at}jhmi.edu Objective To examine whether initiation ...
Correspondence to Dr John H Stone, Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA 02114, USA; jhstone{at}mgh.harvard.edu IgG4-related disease (IgG4-RD) can cause ...
Objective To investigate the rate of serious bacterial, viral or opportunistic infection in patients with rheumatoid arthritis (RA) starting tocilizumab (TCZ) versus tumour necrosis factor inhibitors ...
Correspondence to Dr Kay-Geert A Hermann, Department of Radiology (CCM), Charité – Universitätsmedizin Berlin, Berlin, 10117, Germany; kgh{at}charite.de Objective To compare the performance of a new ...
F8: Back to the future: how to mix the old and new treatments for SLE, Sjögren's and APS ...
3 Amsterdam Rheumatology& Immunology Center, VU University Medical Center, Amsterdam, the Netherlands 4 Medical Humanities, VU Medical Centre, Amsterdam, the Netherlands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results